Dermal metastases in oral cancer after curative treatment: a single institution cohort study

Br J Oral Maxillofac Surg. 2021 Sep;59(7):814-819. doi: 10.1016/j.bjoms.2021.02.026. Epub 2021 Mar 30.

Abstract

Dermal metastasis (DM) is, by definition, the involvement of the skin by cancer cells that originate from cancer elsewhere in the body. The skin is considered a rare site of distant failure in head and neck cancer and DM is the bearer of a poor outcome. Literature about it is limited so this study was undertaken to analyse the factors associated with its incidence and outcomes. A prospectively maintained database on operated cases of oral cancer at a tertiary cancer centre was analysed, and patients who developed dermal metastases during follow up were evaluated. Factors that contributed to early DM and predicted survival after its development were studied. A total of 68 patients (2.8%) had DM as the first presentation of recurrence after a median disease-free period of five months. Early DM was significantly associated with skin involvement by the primary tumour at the time of presentation (p=0.06), extracapsular extension of nodes (p=0.004), and with those who required adjuvant chemotherapy in view of aggressive histology (p=0.021). Median (range) survival after the detection of DM was 97 (5-328) days (3.25 months). Surgical excision of isolated cases was associated with significantly increased survival after detection (p=0.05). Whenever it is feasible without too much morbidity, solitary DM should be excised.

Keywords: cutaneous metastasis; dermal metastasis; distant failure; distant metastasis; oral cancer; skin nodules.

MeSH terms

  • Chemotherapy, Adjuvant
  • Cohort Studies
  • Head and Neck Neoplasms*
  • Humans
  • Mouth Neoplasms* / pathology
  • Mouth Neoplasms* / surgery
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Staging
  • Retrospective Studies